Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study

Archives of Internal Medicine

Volumn 165, Issue 5, 2005, Pages 500-508

  Margolis, Karen L ^a,i   Manson, JoAnn E ^b   Greenland, Philip ^c   Rodabough, Rebecca J ^d   Bray, Paul F ^e   Safford, Monika ^f   Grimm Jr , Richard H ^a   Howard, Barbara V ^g   Assaf, Annlouise R ^h   Prentice, Ross ^d  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g HOWARD UNIVERSITY   (United States)

^h BROWN UNIVERSITY   (United States)

ⁱ Berman Ctr Outcomes and Clin Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; POPULATION RESEARCH; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; EVALUATION STUDIES; FEMALE; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 20044383742     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.5.500     Document Type: Article

References (45)

1. Tracy R. Inflammation in cardiovascular disease. Circulation. 1998;97:2000-2002.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
3. Libby P, Ridker P. Novel inflammatory markers for coronary risk. Circulation. 1999;100:1148-1150.
4. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001;88:10K-15K.
5. Rader D. Inflammatory markers of coronary risk. N Engl J Med. 2000;343:1179-1182.
6. Pearson T, Mensah G, Alexander R, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
7. Cole D, Singian E, Kate L. The long-term prognosis following myocardial infarction, and some factors which affect it. Circulation. 1954;9:321-334.
8. Friedman G, Klatsky A, Siegelaub A. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290:1275-1278.
9. Zalokar J, Richard J, Claude J. Leukocyte count, smoking, and myocardial infarction. N Engl J Med. 1981;304:465-468.
10. Prentice R, Szatrowski T, Fujikura T, Kato H, Mason M, Hamilton H. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol. 1982;116:496-509.
11. Prentice R, Szatrowski T, Kato H, Mason M. Leukocyte counts and cerebrovascular disease. J Chronic Dis. 1982;35:703-714.
12. Schlant R, Forman S, Stamler J, Canner P. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction. Circulation. 1982;66:401-414.
13. Lowe G, Machado S, Krol W, Barton B, Forbes C. White blood cell count and haematocrit as predictors of coronary recurrence and myocardial infarction. Thromb Haemost. 1985;54:700-703.
14. Grimm R, Neaton J, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985;254:1932-1937.
15. Yarnell J, Baker I, Sweetnam P, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative heart disease studies. Circulation. 1991;83:836-844.
16. Phillips A, Neaton J, Cook D, Grimm R, Shaper A. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol. 1992;136:59-70.
17. Kannel W, Anderson K, Wilson P. White blood cell count and cardiovascular disease. JAMA. 1992;267:1253-1256.
18. Manttari M, Manninen V, Koskinen P, et al. Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J. 1992;123:873-877.
19. Olivares R, Ducimetiere P, Claude J. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49-53.
20. Gillum R, Ingram D, Makuc D.. White blood cell count, coronary heart disease, and death: the NHANES 1 Epidemiological Follow-up Study. Am Heart J. 1993;128:855-863.
21. Gilium R, Ingram D, Makuc D. White blood cell count and stroke incidence and death. Am J Epidemiol. 1994;139:894-902.
22. Weijenberg M, Feskens E, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol. 1996;16:499-503.
23. Sweetnam P, Thomas H, Yarnell J, Baker I, Elwood P. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell Studies. Am J Epidemiol. 1997;145:416-421.
24. Folsom A, Wu K, Rosamond W, Sharrett A, Chambless L. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102-1108.
25. Folsom A, Rosamond W, Shahar E, et al; The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation. 1999;100:736-742.
26. Packard C, O'Reilly D, Caslake M, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med. 2000;343:1148-1155.
27. Saito I, Folsom A, Brancati F, Duncan B, Chambless L, McGovern P. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000;133:81-91.
28. Brown D, Giles W, Croft J. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54:316-322.
29. Lee C, Folsom A, Chambless L, Shahar E, Wolfe D. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women. Am J Epidemiol. 2001;154:758-764.
30. Hajj-Ali R, Zareba W, Ezzeddine R, Moss A. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001;88:1221-1224.
31. Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 1998;19:61-109.
32. Anderson G, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative Study Design. Ann Epidemiol. 2003;13:S5-S17.
33. Hays J, Hunt J, Hubbell F, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13:S18-S77.
34. Langer R, White E, Lewis C, Kotchen J, Hendrix S, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13:S107-S121.
35. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol. 1990;43:1327-1335.
36. Patterson R, Kristal A, Tinker L, Carter R, Bolton M, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178-187.
37. Ainsworth B, Haskell W, Leon A, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
38. Ives D, Fitzpatrick A, Bild D. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
39. Pradhan A, Manson J, Rossouw J, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative Observational Study. JAMA. 2002;288:980-987.
40. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, c-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA. 1998;279:1477-1482.
41. Sabatine M, Morrow D, Cannon C, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy. J Am Coll Cardiol. 2002;40:1761-1768.
42. Bickel C, Rupprecht H, Blankenberg S, et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willenbrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002;89:901-908.
43. Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Mänttäri M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J. 2001;141:580-585.
44. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
45. Dinerman J, Mehta J. Endothelial, platelet and leukocyte interactions in ischemie heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol. 1990;16:207-222.